SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 76 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $54,000 | +1.9% | 98,513 | +0.6% | 0.00% | 0.0% |
| Q1 2016 | $53,000 | -56.9% | 97,913 | -28.4% | 0.00% | 0.0% |
| Q4 2015 | $123,000 | -2.4% | 136,833 | -12.0% | 0.00% | -50.0% |
| Q3 2015 | $126,000 | -77.7% | 155,433 | -17.1% | 0.00% | -75.0% |
| Q2 2015 | $564,000 | +121.2% | 187,428 | +79.8% | 0.01% | +100.0% |
| Q1 2015 | $255,000 | +140.6% | 104,219 | +150.4% | 0.00% | +100.0% |
| Q4 2014 | $106,000 | -58.6% | 41,626 | +6.1% | 0.00% | -50.0% |
| Q2 2014 | $256,000 | +8.0% | 39,229 | -21.6% | 0.00% | 0.0% |
| Q4 2013 | $237,000 | +149.5% | 50,023 | +173.5% | 0.00% | +100.0% |
| Q2 2013 | $95,000 | – | 18,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,136,000 | $7,997,000 | 1.56% |
| Healthcare Value Capital, LLC | 200,000 | $510,000 | 0.93% |
| DSC Advisors, L.P. | 450,000 | $1,148,000 | 0.33% |
| Alden Global Capital Ltd | 188,200 | $480,000 | 0.12% |
| Perceptive Advisors | 500,000 | $1,275,000 | 0.11% |
| Baker Brothers Advisors | 3,200,000 | $8,160,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 653,970 | $1,668,000 | 0.07% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,346,948 | $5,985,000 | 0.06% |
| Visium Asset Management, LP | 1,528,356 | $3,898,000 | 0.06% |
| Northeast Financial Consultants Inc | 11,000 | $28,000 | 0.02% |